Causal effects of gut microbiota on sepsis and sepsis-related death: insights from genome-wide Mendelian randomization, single-cell RNA, bulk RNA sequencing, and network pharmacology

Sha Yang,Jing Guo,Zhuo Kong,Mei Deng,Jingjing Da,Xin Lin,Shuo Peng,Junwu Fu,Tao Luo,Jun Ma,Hao Yin,Lin Liu,Jian Liu,Yan Zha,Ying Tan,Jiqin Zhang
DOI: https://doi.org/10.1186/s12967-023-04835-8
IF: 8.44
2024-01-02
Journal of Translational Medicine
Abstract:Abstract Background Gut microbiota alterations have been implicated in sepsis and related infectious diseases, but the causal relationship and underlying mechanisms remain unclear. Methods We evaluated the association between gut microbiota composition and sepsis using two-sample Mendelian randomization (MR) analysis based on published genome-wide association study (GWAS) summary statistics. Sensitivity analyses were conducted to validate the robustness of the results. Reverse MR analysis and integration of GWAS and expression quantitative trait loci (eQTL) data were performed to identify potential genes and therapeutic targets. Results Our analysis identified 11 causal bacterial taxa associated with sepsis, with increased abundance of six taxa showing positive causal relationships. Ten taxa had causal effects on the 28-day survival outcome of septic patients, with increased abundance of six taxa showing positive associations. Sensitivity analyses confirmed the robustness of these associations. Reverse MR analysis did not provide evidence of reverse causality. Integration of GWAS and eQTL data revealed 76 genes passing the summary data-based Mendelian randomization (SMR) test. Differential expression of these genes was observed between sepsis patients and healthy individuals. These genes represent potential therapeutic targets for sepsis. Molecular docking analysis predicted potential drug-target interactions, further supporting their therapeutic potential. Conclusion Our study provides insights for the development of personalized treatment strategies for sepsis and offers preliminary candidate targets and drugs for future drug development.
medicine, research & experimental
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the causal relationship between the gut microbiome and sepsis and its related mortality, and to reveal its underlying mechanisms. Specifically, the researchers hope to solve this problem through the following methods: 1. **Mendelian randomization analysis**: Use genetic variation as an instrumental variable to assess the causal relationship between the gut microbiome and sepsis. This method can reduce the influence of confounding factors in traditional observational studies and provide more reliable causal inferences. 2. **Single - cell RNA sequencing**: Through single - cell RNA sequencing technology, obtain high - resolution cell type and functional characteristics to further understand the interaction between the gut microbiome and sepsis. 3. **Bulk RNA sequencing**: Provide overall gene expression information, verify and supplement the results of single - cell transcriptomics, and ensure the comprehensiveness and accuracy of the study. 4. **Network pharmacology analysis**: By analyzing and docking potential therapeutic drugs, explore new treatment strategies and provide clues for personalized treatment of sepsis. ### Main findings - **Causal relationship**: The study found that 11 bacterial taxa have a causal relationship with sepsis, and the increased abundance of 6 taxa is positively correlated with sepsis. For 28 - day survival rate, 10 taxa showed a causal effect, and the increased abundance of 6 taxa was associated with a higher survival rate. - **Genes and functions**: By integrating GWAS and eQTL data, the researchers found 76 genes through Mendelian randomization tests. These genes showed differential expression between sepsis patients and healthy individuals and may become potential therapeutic targets. - **Single - cell analysis**: The results of single - cell RNA sequencing showed that certain genes showed significant expression changes in specific cell types, such as the up - regulation of PLCG2 in immune cells and the up - regulation of BCL6 in Pre - B cells, and these changes may be related to the occurrence and development of sepsis. ### Conclusion This study provides preliminary candidate targets and drugs for personalized treatment strategies of sepsis, helps to better understand the mechanism of the gut microbiome in the occurrence and development of sepsis, and provides new clues for future drug development.